Lincomycin-2-phosphate is a phosphate ester derivative of lincomycin, a lincosamide antibiotic. It is specifically identified as a known impurity or degradation product of clindamycin phosphate, the water-soluble prodrug form of clindamycin hydrochloride used in topical and injectable formulations. Its chemical structure features the core lincomycin sugar moiety modified with a phosphate group. This compound is of primary importance in the pharmaceutical industry as a reference standard for quality control. It is used in analytical methods, such as high-performance liquid chromatography (HPLC), to monitor, identify, and quantify this specific impurity during the manufacturing and stability testing of clindamycin phosphate drug products. Ensuring the impurity profile meets regulatory specifications is critical for drug safety and efficacy. As a defined impurity, its presence and levels are controlled according to guidelines from pharmacopoeias like USP, EP, and ICH. Handling requires standard laboratory precautions for chemical substances.